The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Naruya Tomita

Department of Geriatric Medicine

Osaka University Graduate School of Medicine

2-15 Yamada-oka

Suita 565-0871



Name/email consistency: high



  • Department of Geriatric Medicine, Osaka University Graduate School of Medicine, 2-15 Yamada-oka, Suita 565-0871, Japan. 2002 - 2004
  • Department of General Medicine, Osaka University Hospital, Suita, Japan. 2001 - 2003


  1. Antisense oligonucleotides as a powerful molecular strategy for gene therapy in cardiovascular diseases. Tomita, N., Morishita, R. Curr. Pharm. Des. (2004) [Pubmed]
  2. Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis. Tomita, N., Kim, J.Y., Gibbons, G.H., Zhang, L., Kaneda, Y., Stahl, R.A., Ogborn, M., Venderville, B., Morishita, R., Baran, D., Dzau, V.J. Int. J. Mol. Med. (2004) [Pubmed]
  3. Application of decoy oligodeoxynucleotides-based approach to renal diseases. Tomita, N., Azuma, H., Kaneda, Y., Ogihara, T., Morishita, R. Curr. Drug. Targets (2004) [Pubmed]
  4. Gene therapy with transcription factor decoy oligonucleotides as a potential treatment for cardiovascular diseases. Tomita, N., Azuma, H., Kaneda, Y., Ogihara, T., Morishita, R. Curr. Drug. Targets (2003) [Pubmed]
  5. Development of novel decoy oligonucleotides: advantages of circular dumb-bell decoy. Tomita, N., Tomita, T., Yuyama, K., Tougan, T., Tajima, T., Ogihara, T., Morishita, R. Curr. Opin. Mol. Ther. (2003) [Pubmed]
  6. Transcription factors as molecular targets: molecular mechanisms of decoy ODN and their design. Tomita, N., Ogihara, T., Morishita, R. Curr. Drug. Targets (2003) [Pubmed]
  7. Therapeutic potential of decoy oligonucleotides strategy in cardiovascular diseases. Tomita, N., Ogihara, T., Morishita, R. Expert. Rev. Cardiovasc. Ther (2003) [Pubmed]
  8. Potential therapeutic applications of decoy oligonucleotides. Tomita, N., Morishita, R., Tomita, T., Ogihara, T. Curr. Opin. Mol. Ther. (2002) [Pubmed]
  9. Therapeutic approach to familial hypercholesterolemia by HVJ-liposomes in LDL receptor knockout mouse. Tomita, N., Morishita, R., Koike, H., Hashizume, M., Notake, M., Fujitani, B., Kaneda, Y., Horiuchi, M., Ogihara, T. Int. J. Mol. Med. (2002) [Pubmed]
  10. Targeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes. Tomita, N., Morishita, R., Yamamoto, K., Higaki, J., Dzau, V.J., Ogihara, T., Kaneda, Y. J. Gene. Med (2002) [Pubmed]
  11. Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB. Tomita, N., Morishita, R., Tomita, S., Kaneda, Y., Higaki, J., Ogihara, T., Horiuchi, M. Exp. Nephrol. (2001) [Pubmed]
  12. A family with von Hippel-Lindau disease revealed by pheochromocytoma. Tomita, N., Moriguchi, A., Yamasaki, K., Taniyama, Y., Kotani, N., Hashiya, N., Yoshida, M., Yao, M., Higaki, J., Ogihara, T. Hypertens. Res. (2001) [Pubmed]
WikiGenes - Universities